JENNIFER COX: Open Payments
NPI 1396129813 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 21 payments from 8 companies in 2025. Trend: 2023 $292 · 2024 $375 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $232 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| Lundbeck LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
Products named: INVEGA SUSTENNA, FANAPT, INGREZZA, UZEDY, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, REXULTI.
Industry payments across GA — which companies pay providers there.
